
Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project
Despite advances in treatments, 30% to 50% of stage III-IV head and neck squamous cell carcinoma (HNSCC) patients relapse within 2 years after treatment. The Big... Leggi tutto.

Genomics features (GF) and integration with MRI radiomics features (RF) to develop a prognostic model in oral cavity squamous cell carcinoma (OSCC)
Questo lavoro consiste nello sviluppo di un modello prognostico nel carcinoma a cellule squamose della cavità orale basato su caratteristiche genomiche e caratteristiche... Leggi tutto.